Trials / Unknown
UnknownNCT02105194
Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Cerebral Decompression Illness
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- Sponsor
- Paul G. Harch, M.D. · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Chart review of patients who received hyperbaric oxygen therapy for cerebral decompression illness who also underwent SPECT brain blood flow imaging to see if SPECT brain imaging tracks and is consistent with the clinical condition of the patients.
Detailed description
SPECT brain imaging has been shown to be the most sensitive imaging modality for cerebral decompression illness. This study is a retrospective review of the PI's experience using SPECT brain imaging in the diagnosis and treatment of all phases of cerebral decompression illness over the past two decades. The purpose of the study is to see if the functional imaging is consistent with the clinical condition and cognitive testing. Chart review of symptoms, and physical exam findings will be compared before and after treatment to SPECT brain imaging radiological readings to assess concordance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hyperbaric oxygen therapy | total body exposure to greater than atmospheric pressure oxygen |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2017-12-01
- Completion
- 2018-12-01
- First posted
- 2014-04-07
- Last updated
- 2017-04-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02105194. Inclusion in this directory is not an endorsement.